Exabis Library
Welcome to the e-CCO Library!
P604: Interest in the addition of azathioprine (AZA) to the switch of anti-TNF in IBD patients in loss of response with undetectable anti-TNF trough levels and anti-drug antibodies: A prospective randomised trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P604: Usefulness of stool hemoglobin and fecal calprotectin for detecting of mild to moderate ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P605 Eight-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P605: CRP reduction rate following initiation of anti-tumour necrosis factor-α induction therapy predicts secondary loss of response in patients with Crohn's disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P605: Development and validation of an objective disability index for Inflammatory Bowel Disease patients (ODIBD)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P605: Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P605: Rapid detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the reference biologic or the biosimilar CT-P13: performance comparison with ELISA
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P605: Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P605: Transanal minimally invasive proctectomy (TaMIP) in patients with Crohn’s disease: A cohort study from the TaTME international database
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P606 Exclusive enteral nutrition with a polymeric diet is efficacious in inducing remission in adults with active Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P606: Adherence to endoscopic surveillance guidelines for advanced lesions and colorectal cancer in Inflammatory Bowel Disease in Spain: a collaborative study of AEG and GETECCU.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P606: Health-related utility weights in Crohn's disease patients with perianal fistula
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P606: Intestinal fatty acid binding protein parallels temporal changes in Harvey-Bradshaw Index and TNFα in response to infliximab in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P606: Significant regional differences in referral patterns for bowel resection in Crohn's disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P606: Steroid use in inflammatory bowel disease patients on biological therapy in Montenegro
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P606: Use of TNF-α-antagonists and systemic steroids is associated with attenuated immunogenicity against SARS-CoV-2 in fully vaccinated patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P607 Cost-effectiveness of vedolizumab IV vs. adalimumab SC for moderately to severely active ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P607: Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade®) to the biosimilar SB2 (Flixabi®) in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P607: Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P607: Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM